Covis Pharma, the maker of Makena, is planning the withdrawal after a study failed to confirm the drug works Makena was the only drug approved by the FDA to reduce the risk of preterm birth in women with a history of early deliveries.
Covis Pharma Group said it will stop selling itsNous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:
just call it a supplement and nobody says diddly
How did it get approved in the first place?
Good, do aducanumab next.
Wtf are these things let out before we know this. Jesus f----- Christ